Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Januvia (sitagliptin phosphate) Tablets, Merck & Co., Approval | Janumet (sitagliptin/metformin hydrochloride) Tablets, Merck & Co., Approval | Januvia (sitagliptin) Tablets, Merck & Co., New or Modified Indication | Janumet (sitagliptin/metformin hydrochloride fixed-dose combination) Tablets, Merck & Co., Labeling Revision | Janumet (sitagliptin phosphate and metformin hydrochloride) Tablets, Merck & Co., Inc., Manufacturing Change or Addition | Januvia (sitagliptin phosphate) Tablets, Merck & Co., Inc., Labeling Revision | Januvia (sitagliptin phosphate) Tablets, Merck & Co., Inc., Supplement | Janumet (metformin hydrochloride and sitagliptin phosphate) Tablets, Merck & Co., Inc., Labeling Revision | Januvia (sitagliptin phosphate) Tablets, Merck & Co., Inc., Labeling Revision | Janumet (metformin hydrochloride and sitagliptin phosphate) Tablets, Merck, Efficacy Supplement with Clinical Data to Support | Januvia (sitagliptin phosphate) Tablets, Merck Co. Inc., Efficacy Supplement with Clinical Data to Support | Janumet (metformin hydrochloride and sitagliptin phosphate) Tablets, Merck Sharp and Dohme Corp., Labeling Revision | Januvia (sitagliptin phosphate) Tablets, Merck Sharp and Dohme Corp., Labeling Revision | Janumet (sitagliptin phosphate and metformin hydrochloride) Tablets, Merck Sharp and Dohme Corp., Labeling Revision | Januvia (sitagliptin phosphate) Tablets, Merck Sharp and Dohme Corp., Labeling Revision | Janumet (sitagliptin phosphate and metformin hydrochloride) Tablets, Merck Sharp and Dohme Corp., Labeling Revision | Juvisync (sitagliptin and simvastatin) Tablets, Merck Sharp & Dohme Corp., Approval ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com